FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)
FL3X
FL3X: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes
2 other identifiers
interventional
258
1 country
2
Brief Summary
The purpose of this study is to see if a behavioral intervention for adolescents with type 1 diabetes will improve adherence to T1D self-management activities and improve diabetes outcomes. We expect the intervention to improve diabetes outcomes when compared to usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2014
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 26, 2011
CompletedFirst Posted
Study publicly available on registry
January 31, 2011
CompletedStudy Start
First participant enrolled
May 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedApril 29, 2021
February 1, 2019
3.6 years
January 26, 2011
April 28, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hemoglobin A1c
HbA1c will be measured to determine impact on glucose control
0, 3, 6, 12, 18, 24, 30 months
Secondary Outcomes (6)
Motivation
0, 3, 6, 12, 18, 24, 30 months
Problem solving skills
0, 3, 6, 12, 18, 24, 30 months
Hypoglycemia
0, 6, 18 mo
Diabetes self-management behaviors
0, 3, 6, 12, 18, 24, 30 months
Risk factors for diabetes complications
0, 3, 6, 12, 18, 24, 30 months
- +1 more secondary outcomes
Other Outcomes (1)
Cost of intervention delivery
0-30 months
Study Arms (2)
Control
NO INTERVENTIONParticipants randomized control will continue with usual clinical care.
Intervention
EXPERIMENTALParticipants randomized to intervention will receive the "FL3X Flexible Lifestyle Empowering Change" intervention. Adolescents will be paired with a health coach to help learn strategies for improving diabetes control
Interventions
The FL3X Adaptive Intervention is designed to increase adherence to T1D self-management including medical management (blood sugar testing and insulin dosing), diet, and physical activity. FL3X relies on MI, and problem-solving skills training (PSST) as the basis for the counseling strategy, and creates a coherent integration across three key components of 1) behavior family systems therapy focused on family communications and teamwork; 2) individualized diabetes education in response to knowledge gaps relevant to behavioral goal attainment; and 3) use of currently available communications technology to support behavioral goal attainment through participant-defined reminders and motivational boosters, and/or peer support.
Eligibility Criteria
You may qualify if:
- type 1 diabetes with duration at least 12 months
- between ages 12-16 years at registration
- poor glycemic control (A1c 8.0-13.0%)
- parent/guardian willing to also participate
- not planning on moving in the following 18 months
You may not qualify if:
- pregnant (if female)
- diabetes type 2 or gestational
- Pre-existing systemic chronic disease (drug abuse, cancer, certain psychiatric conditions)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of North Carolina, Chapel Hilllead
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator
- Children's Hospital Medical Center, Cincinnaticollaborator
- University of Colorado, Denvercollaborator
- University of Washingtoncollaborator
- Nemours Children's Cliniccollaborator
- University of Pittsburghcollaborator
Study Sites (2)
University of Colorado Barbara Davis Center for Childhood Diabetes
Aurora, Colorado, 80045, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45206, United States
Related Publications (5)
Cristello Sarteau A, Crandell J, Seid M, Kichler JC, Maahs DM, Wang J, Mayer-Davis E. Characterization of youth goal setting in the self-management of type 1 diabetes and associations with HbA1c: The Flexible Lifestyle Empowering Change trial. Pediatr Diabetes. 2020 Nov;21(7):1343-1352. doi: 10.1111/pedi.13099. Epub 2020 Sep 1.
PMID: 32741045DERIVEDKahkoska AR, Lawson MT, Crandell J, Driscoll KA, Kichler JC, Seid M, Maahs DM, Kosorok MR, Mayer-Davis EJ. Assessment of a Precision Medicine Analysis of a Behavioral Counseling Strategy to Improve Adherence to Diabetes Self-management Among Youth: A Post Hoc Analysis of the FLEX Trial. JAMA Netw Open. 2019 May 3;2(5):e195137. doi: 10.1001/jamanetworkopen.2019.5137.
PMID: 31150087DERIVEDMayer-Davis EJ, Maahs DM, Seid M, Crandell J, Bishop FK, Driscoll KA, Hunter CM, Kichler JC, Standiford D, Thomas JM; FLEX Study Group. Efficacy of the Flexible Lifestyles Empowering Change intervention on metabolic and psychosocial outcomes in adolescents with type 1 diabetes (FLEX): a randomised controlled trial. Lancet Child Adolesc Health. 2018 Sep;2(9):635-646. doi: 10.1016/S2352-4642(18)30208-6. Epub 2018 Jul 30.
PMID: 30119757DERIVEDZhong VW, Crandell JL, Shay CM, Gordon-Larsen P, Cole SR, Juhaeri J, Kahkoska AR, Maahs DM, Seid M, Forlenza GP, Mayer-Davis EJ. Dietary intake and risk of non-severe hypoglycemia in adolescents with type 1 diabetes. J Diabetes Complications. 2017 Aug;31(8):1340-1347. doi: 10.1016/j.jdiacomp.2017.04.017. Epub 2017 Apr 20.
PMID: 28476567DERIVEDMayer-Davis EJ, Seid M, Crandell J, Dolan L, Lagarde WH, Letourneau L, Maahs DM, Marcovina S, Nachreiner J, Standiford D, Thomas J, Wysocki T. Flexible Lifestyles for Youth (FL3X) behavioural intervention for at-risk adolescents with Type 1 diabetes: a randomized pilot and feasibility trial. Diabet Med. 2015 Jun;32(6):829-33. doi: 10.1111/dme.12641. Epub 2014 Dec 30.
PMID: 25424501DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth Mayer-Davis, PhD
UNC-CH
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2011
First Posted
January 31, 2011
Study Start
May 1, 2014
Primary Completion
December 1, 2017
Study Completion
January 1, 2018
Last Updated
April 29, 2021
Record last verified: 2019-02